The Blood Test That Could Detect Alzheimer’s Years Before Symptoms | Mike Banville - CEO, ALZpath

Episode notes

Send us Fan Mail What if a simple blood test could detect Alzheimer’s years - maybe even decades - before symptoms ever appear? Mike Banville is the Chief Executive Officer of ALZpath ( ), a company at the forefront of transforming how Alzheimer’s disease is detected and monitored through cutting-edge blood-based diagnostics. Mike is a seasoned global executive with a track record of scaling businesses, driving operational transformation, and executing strategic growth through both organic expansion and acquisitions. Prior to ALZpath, he served as CEO of SSB - doubling revenue and shifting the business to a predominantly recurring revenue model. Earlier in his career, Mike spent over two decades at IHS Markit, where he held multiple senior leadership roles across strategy, sales, marketing, and global operations. There, he helped scale the Telecommunications, Media, and Technology division through acquisitions and product integration, while also leading global offshoring strategy and climate-focused market development initiatives.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

• EP 247: Why neurons accumulate mutations like clockwork: Somatic mosaicism and neurodegeneration with Christopher Walsh of Boston Children's HospitalThe Genetics Podcast · on Alzheimers Disease98 / 100
• The Scientist Turned VC Funding the Cure for Aging with Omri Amirav-DroryVentures from The Valley · on longevity81 / 100
• 78. Andrea Hogan, Prior CMO of Qualcomm & Camino de Santiago finisher!Curiosity with Kristen · on Alzheimers Disease66 / 100
• Building Brain-Healthy WorkplacesTeam Building Saves The World · on Dementia60 / 100
• Biology Matters TrailerBiology Matters · on Dementia31 / 100
• Dementia in Down Syndrome: Is It Inevitable?University of California Audio Podcasts · on Dementia

• Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100
• The Blood Test That Could Change Cancer Treatment Forever | Eric Matthews - General Manager, Biopharma, Natera65 / 100
• How Female Biology Shapes Skin Disease Across a Lifetime | Dr. Doral Fredericks, PharmD, MBA - Vice President and Head of Global Medical Affairs and Outcomes Research, Organon56 / 100
• 55 Years Without a Diagnosis | Can AI Solve The Undiagnosed Condition Blind Spot? | Haresh Patel - Founder and CEO, Sanare Health AI70 / 100
• How Regenerative Medicine Is Reinventing Breast Reconstruction | Dr. Claudia Chavez-Munoz, MD, PhD - Chief Scientific Officer and Co-Founder - Conexeu Sciences